Loading
Latest filing published 19 Jan 2023 for Idera Pharmaceuticals, INC.. Read the official filing
No signal scores available.
Daniel Salain appears in our data through filings on Idera Pharmaceuticals, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 28 September 2022 to 17 January 2023, the count stands at 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 19 January 2023, reports an option exercise in Idera Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations